Keyphrases
ST-elevation Myocardial Infarction (STEMI)
81%
Transcatheter Aortic Valve Implantation
71%
Acute Kidney Injury
70%
Myocardial Infarction Patients
61%
Long-term Mortality
36%
Coronary Angiography
32%
All-cause Mortality
32%
Coronary Artery Disease
32%
Transcatheter Aortic Valve Replacement
31%
Percutaneous Coronary Intervention
31%
Primary Percutaneous Coronary Intervention
29%
Confidence Interval
27%
Percutaneous Intervention
27%
Consecutive Patients
27%
C-reactive Protein
25%
Erectile Dysfunction
24%
Hazard Ratio
23%
Acute Coronary Syndrome
21%
High-sensitivity C-reactive Protein (hs-CRP)
21%
Clinical Outcomes
20%
Severe Aortic Stenosis
18%
Acute Myocardial Infarction
18%
Red Cell Distribution Width
18%
Left Ventricular Ejection Fraction
18%
Major Adverse Cardiovascular Events
17%
Prognostic Implications
17%
Echocardiography
16%
Erythrocyte Aggregation
16%
Cardiovascular Risk
15%
Cancer Therapeutics-related Cardiac Dysfunction
15%
Inflammation
15%
COVID-19
15%
Cardio-oncology
14%
Renal Impairment
14%
Heart Failure
14%
Odds Ratio
13%
Left Ventricular Function
12%
Anthracyclines
12%
Temporal Trends
12%
Post-procedural
12%
Global Longitudinal Strain
12%
Metabolic Syndrome
12%
Inflammatory Bowel Disease
12%
Cardiotoxicity
12%
Forced Diuresis
11%
Israeli
11%
Normal Coronary Arteries
11%
Stable Angina
10%
Long-term Survival
10%
Peri-procedural
10%
Medicine and Dentistry
Percutaneous Aortic Valve Replacement
100%
ST Segment Elevation Myocardial Infarction
53%
Acute Kidney Injury
51%
Coronary Artery Disease
36%
Prevalence
32%
Percutaneous Coronary Intervention
29%
Primary Percutaneous Coronary Intervention
26%
Myocardial Infarction
26%
Aortic Stenosis
24%
Congestive Heart Failure
22%
All Cause Mortality
22%
Malignant Neoplasm
22%
C Reactive Protein
22%
Cardiovascular System
20%
Percutaneous Intervention
20%
Echocardiography
19%
Hazard Ratio
19%
Coronary Angiography
18%
Erectile Dysfunction
18%
COVID-19
18%
Breast Cancer
16%
Neutrophil
16%
Cardiovascular Disease
16%
Acute Heart Infarction
15%
Heart Left Ventricle Ejection Fraction
14%
Oncology
14%
Odds Ratio
14%
Acute Coronary Syndrome
14%
Heart Left Ventricle Function
14%
Ejection Fraction
13%
Diabetes Mellitus
13%
Anthracycline
13%
Diseases
12%
Left Ventricle
12%
Cardiotoxicity
12%
Lymphocyte
12%
Kidney Function
12%
Coronary Artery
11%
Anemia
11%
Biological Marker
10%
Carotid Atherosclerosis
10%
Diuresis
9%
Lung
9%
Systolic Dysfunction
9%
Cardiovascular Risk
9%
Aortic Valve Prosthesis
9%
Metabolic Syndrome
9%
Erythrocyte Aggregation
9%
Red Blood Cell Distribution Width
9%
Coronary Circulation
9%